Pediatric rheumatology

Assessing the impact of the iPeer2Peer program for adolescents with juvenile idiopathic arthritis: a mixed-methods randomized controlled trial

Pediatr Rheumatol Online JPublished Randomised controlled trial

Authors' conclusion

While the iPeer2Peer did not result insignificant changes in clinical outcomes, both mentors and mentees were satisfied with the program and felt that mentorship provided real-world benefits for disease management and overall wellbeing.

Study context

Population
Youth aged 12–18 with Juvenile Idiopathic Arthritis (JIA)mean age 14.4 ± 1.9 years, 78% female
Participants
164 participants
Comparison
iPeer2Peer peer mentoring vs standard care
  • iPeer2Peern = 81
  • Standard caren = 83reference
Primary endpoint
Self-management, measured using the TRANSITION-Q
Methodological detailswaitlist, mixed-methods, Proposed sample size not reached due to recruitment challenges, likely impacted by the COVID-19 pandemic
  • Waitlist
  • Mixed-methods
  • Proposed sample size not reached due to recruitment challenges, likely impacted by the COVID-19 pandemic

Primary result

As reported in the abstract

Self-management (TRANSITION-Q)
  • No significant improvement in self-management
  • iPeer2Peer vs Standard care: P = 0.7

Secondary outcomes

Health related quality of life (HRQL), pain, emotional distress, disease knowledge, self-efficacy, perceived social support

No significant improvement in any of the secondary outcomes

Satisfaction (content analysis of interviews and focus groups) · upon study completion

Mentees valued conversing with mentors who empathized with their disease experience; mentors found it fulfilling to support mentees

Original publication

Assessing the impact of the iPeer2Peer program for adolescents with juvenile idiopathic arthritis: a mixed-methods randomized controlled trial. Pediatr Rheumatol Online J. Published 27 December 2024. doi:10.1186/s12969-024-01052-5

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.